Table 1.
Parameter | HbA1c evaluation cohort (n = 740) |
---|---|
Age, y | 53.8 ± 8.8 |
Female, # (%) | 468 (63) |
Body mass index | 35.6 ± 8.5a |
Baseline HbA1c, % | 7.7 ± 1.7 |
Medication use, # (%) | |
Sulfonylurea | 192 (25.9) |
Insulin | 230 (31.1) |
CGM delivered, # (%) | 340 (45.9) |
Geography, # (%)18 | |
Urban | 512b (70.0) |
Rural | 222b (30.0) |
Data are mean ± SD unless otherwise indicated.
CGM, continuous glucose monitor.
n = 663, bn = 734.